Cibc World Market Inc. Delcath Systems, Inc. Transaction History
Cibc World Market Inc.
- $47.5 Billion
- Q2 2025
A detailed history of Cibc World Market Inc. transactions in Delcath Systems, Inc. stock. As of the latest transaction made, Cibc World Market Inc. holds 146,610 shares of DCTH stock, worth $1.63 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
146,610
Previous 177,893
17.59%
Holding current value
$1.63 Million
Previous $2.26 Million
11.97%
% of portfolio
0.0%
Previous 0.01%
Shares
15 transactions
Others Institutions Holding DCTH
# of Institutions
121Shares Held
13.2MCall Options Held
105KPut Options Held
38.7K-
Vanguard Group Inc Valley Forge, PA1.61MShares$17.9 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY813KShares$9.02 Million0.25% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il803KShares$8.92 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA703KShares$7.81 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA570KShares$6.32 Million1.64% of portfolio
About DELCATH SYSTEMS, INC.
- Ticker DCTH
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 8,597,680
- Market Cap $95.4M
- Description
- Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan hydrochloride for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling syste...